Neoplasm Metastasis  >>  paclitaxel trevatide (ANG1005)  >>  Phase 2
Welcome,         Profile    Billing    Logout  

2 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
paclitaxel trevatide (ANG1005) / Angiochem
GRABM-L, NCT01497665: GRN1005 in Non-Small Cell Lung Cancer (NSCLC) Patients With Brain Metastases

Terminated
2
16
Canada, US
GRN1005, ANG1005
Angiochem Inc
Non-small Cell Lung Cancer (NSCLC) With Brain Metastases
01/13
02/13
GRABM-B, NCT01480583: GRN1005 Alone or in Combination With Trastuzumab in Breast Cancer Patients With Brain Metastases

Checkmark P2 data: SABCS 2012
Dec 2012 - Dec 2012: P2 data: SABCS 2012
Completed
2
85
US
GRN1005, ANG1005, Trastuzumab, Herceptin, 18F-FLT, 18F-fluorothymidine
Angiochem Inc
Breast Cancer, Brain Metastases
06/15
10/15

Download Options